MSA Safety Reports 1st Elastomeric Respirator Without Exhalation Valve Is Approved by NIOSH

November 25, 2020

MSA Safety today reported that its next-generation Advantage 290 LS Air-Purifying Respirator (APR) is the first of its kind — designed without an exhalation valve — to receive approval from the National Institute for Occupational Safety and Health (NIOSH).

MSA Safety notes an elastomeric half-mask device, the Advantage 290 LS Respirator covers a wearer’s nose and mouth and utilizes twin filters to provide respiratory protection.

The U.S. Centers for Disease Control and Prevention (CDC) advises that NIOSH-approved respirators, including elastomeric half-mask respirators (EHMRs), are appropriate for use against SARS-CoV-2 in healthcare settings.  This established class of respirator can play a critical role in the nation’s response to COVID-19 and, importantly, bolster future readiness for similar microbial viruses and other emergencies.

In response to the global shortage of personal protective equipment (PPE), MSA has been working throughout the year with healthcare professionals to identify the respiratory protection needs of those on the front line of the pandemic.  Some applications within healthcare require a sterile environment, and one critical component to ensuring a sterile environment is source control. The Advantage 290 Respirator is the first EHMR to function without an exhalation valve, making it a new respiratory protection option that provides both personal protection and source control.  In addition, the new respirator gives healthcare facilities greater optionality and flexibility in developing their respiratory protection programs in accordance with Occupational Safety and Health Administration standards.

“Given the reusable design and nature of elastomeric respirators, there are many benefits of deploying a respiratory protection program that incorporates EHMRs, including cost-efficiency, reduced space requirements for PPE warehousing, and fewer concerns associated with PPE insecurities during a pandemic,” said Greg Martin, MSA Vice President of Product Strategy and Development.

Mr. Martin added that EHMRs also help mitigate concerns about product expiration while conferring additional benefits, like environmental sustainability, through extended use and reuse capability. “With the Advantage 290 model, our team went a step further and developed a respirator that has the potential to be an even more appealing option – today and down the road – for healthcare systems everywhere as they assess plans for the future and their own pandemic preparedness,” he said.

The Advantage 290 Respirator, which will be available for preorder in December 2020, will be produced at MSA Safety’s subsidiary operation in Jacksonville, N.C.

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.